Micast-F Tablet
By Micast-F
Rx
10 Tablet in a Strip

Composition
Montelukast(10mg) + Fexofenadine(180mg)

Manufacturer - Malliot Pharmaceutical
Ward No. 7, Buddi Siswan Road, District - Mohali, Kurali- 140103, Punjab, India

Expires on or after
October, 2025

liver
Micast-F Tablet is likely safe for individuals with liver disease based on the limited data available. It indicates that adjusting the dosage of Micast-F Tablet may not be necessary for these patients. It is advisable to consult with your doctor regarding the use of this medication to ensure its safety and efficacy in liver-related issues.

kidney
Micast-F Tablet should be used carefully in patients with kidney problems. Adjusting the dosage may be necessary, so consult your doctor. It might lead to increased drowsiness in individuals with advanced kidney disease.

alcohol
Caution is advised when consuming alcohol with Micast-F Tablet. It is recommended to consult your doctor regarding alcohol intake while taking this medication.

driving
Micast-F Tablet may reduce alertness, cause vision changes, or induce drowsiness and dizziness. It is advised not to drive if experiencing these effects.

pregnancy
Micast-F Tablet should be avoided during pregnancy as it may be harmful to the developing baby, based on findings from animal studies. Please consult your doctor for further guidance.

breastfeeding
Micast-F Tablet is considered safe while breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹179.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024